Agile Therapeutics, Inc.
AGRX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$25 | -$75 | -$52 |
| Dep. & Amort. | $0 | $2 | $2 | $0 |
| Deferred Tax | -$6 | $0 | $5 | $0 |
| Stock-Based Comp. | $2 | $2 | $3 | $3 |
| Change in WC | $7 | -$2 | -$3 | $0 |
| Other Non-Cash | $1 | -$12 | $2 | $1 |
| Operating Cash Flow | -$10 | -$36 | -$65 | -$47 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$55 |
| Inv. Sales/Matur. | $0 | $0 | $40 | $15 |
| Other Inv. Act. | $0 | -$0 | $40 | -$0 |
| Investing Cash Flow | $0 | -$0 | $39 | -$41 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$17 | $0 | $20 |
| Stock Issued | $8 | $35 | $30 | $48 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $15 | $4 | $0 | -$0 |
| Financing Cash Flow | $7 | $22 | $30 | $68 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$14 | $5 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5 | $19 | $14 | $34 |
| End Cash | $3 | $5 | $19 | $14 |
| Free Cash Flow | -$10 | -$36 | -$65 | -$48 |